🔎 Trials Near Me

Početna › Difuzni veliki B-stanični limfom › Illinois › Chicago

Kliničke studije za Difuzni veliki B-stanični limfom u gradu Chicago, IL

18 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Chicago i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

U tijeku regrutacijaFaza 2
  • Northwestern University - Feinberg School of Medicine, Chicago
  • Rush University Medical Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06500273

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

U tijeku regrutacijaFaza 2
  • Northwestern University, Chicago
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06649812

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

U tijeku regrutacijaFaza 1
  • The University of Chicago Medical Center (UCMC), Chicago
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07101328

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

U tijeku regrutacijaFaza 1
  • University of Chicago Comprehensive Cancer Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT05272384

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

U tijeku regrutacijaFaza 1/2
  • University of Chicago, Chicago
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT07284433

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

U tijeku regrutacijaFaza 1/2
  • University of Chicago Medical Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT04104776

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

U tijeku regrutacijaOpažajna studija
  • Robert H Lurie Cancer Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

U tijeku regrutacijaFaza 3
  • Northwestern, Chicago
  • University of Chicago, Chicago
Od 18 godina i više · Oba spola · Ažurirano 4. kol 2026. · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

U tijeku regrutacijaFaza 2
  • Robert H Lurie Cancer Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

U tijeku regrutacijaFaza 1
  • University of Illinois at Chicago, Chicago
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT05077527

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

U tijeku regrutacijaFaza 1
  • Northwestern University, Chicago
Od 18 godina i više · Oba spola · Ažurirano 9. srp 2026. · NCT06015880

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

U tijeku regrutacijaFaza 1
  • Northwestern University, Chicago
Od 18 godina i više · Oba spola · Ažurirano 2. srp 2026. · NCT05131022

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

U tijeku regrutacijaFaza 1/2
  • University of Illinois at Chicago Cancer Center, Chicago
Od 12 do 95 godina · Oba spola · Ažurirano 15. tra 2026. · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

U tijeku regrutacijaFaza 1
  • The University of Chicago Medical Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 20. ožu 2026. · NCT04830137

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

U tijeku regrutacijaFaza 2
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 2. velj 2026. · NCT05633615

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

U tijeku regrutacijaFaza 2
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 20. lis 2025. · NCT05890352

A Study of NX-1607 in Adults With Advanced Malignancies

U tijeku regrutacijaFaza 1
  • University of Chicago, Chicago
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2025. · NCT05107674

Studije za Difuzni veliki B-stanični limfom u drugim gradovima

Ostale studije u gradu Chicago

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.